Home / VA / Home Health Care Services / Notice

Hazardous Drug Compounding Service for the Louis A Johnson VA Medical Center

Updated

Special Notice from the Department of Veterans Affairs. Due Nov 24, 2026, 3:00 PM (UTC-5), 6 days left.

Be among the first to see new Home Health Care Services contracts
Only new notices that match, once a day.
Title as postedQ517--Hazardous Drug Compounding Service for the Louis A Johnson VA Medical Center
Solicitation number36C24527P0090
AgencyDepartment of Veterans Affairs
Office245-Network Contract Office 5 (36C245)
Notice typeSpecial Notice
Set-asideNone
Trade (NAICS)Home Health Care Services (621610)
Product or service codeQ517
PostedNov 17, 2026
Response deadlineNov 24, 2026, 3:00 PM (UTC-5) (6 days left)
Add the deadline toGoogle Calendar · Apple / Outlook (.ics)
Official notice
Send to a teammate

Bid documents (1)

Paid members download every document from this page, or buy this bid alone.

Description

DEPARTMENT OF VETERANS AFFAIRS Justification and Approval (J&A) For Other Than Full and Open Competition (>SAT) Acquisition Plan Action ID: 36C245-27-AP-1021 Contracting Activity: Department of Veterans Affairs, VISN 05, NC05, Louis A Johnson VA Medical Center 1 Medical Center Drive Clarksburg, WV 26301 PR# 540-27-1-036-0349 Nature and/or Description of the Action Being Approved: The Louis A Johnson VA Medical Center Pharmacy IV room remains out of service due to ongoing flood remediation and displacement of essential compounding operations.

This disruption has left our facility unable to compound hazardous medications needed for Oncology patients, placing timely access to prescribed treatments at risk. A new contract with an external provider to compound and ship these medications to the facility is essential to maintain continuity of care, prevent treatment delays, and sustain Oncology services in the interim of the compounding capabilities being restored.

Due to the nature of services, there exists an unusual and compelling urgent need for this highly specialized service. The medical center requires the use of contractor due to the medical center s IV compounding room being down due to flood remediation, upgrades and recertification of the IV room and pharmacists/techs when re-opened. Existing contractual funding has been exhausted, and immediate contractual action is required to ensure continuity of these critical Oncology support services pending award of the follow-on procurement.

The estimated value is $500,000.00. Description of Supplies/Services Required to Meet the Agency s Needs: The Clarksburg VA Medical Center requires emergency contract support to compound and ship hazardous medications for oncology patients. Flood remediation has displaced essential pharmacy operations and made the Pharmacy IV room unavailable, preventing on-site preparation.

The contractor shall provide all chemotherapy agents, IV tubing, closed-system drug-transfer devices, and other necessary supplies. All hazardous chemotherapy agents shall be aseptically compounded according to patient-specific orders. The Medical Center can identify treatment needs including patient volume and treatment duration only one week in advance.

Each week, the Clinical Pharmacy Practitioner will email the contractor a list of medications to be compounded and shipped to the Medical Center for patient treatment. Statutory Authority Permitting Other than Full and Open Competition: ( ) (1) Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 USC §3304(a)(1) as implemented by RFO 6.103-1; (X ) (2) Unusual and Compelling Urgency per 41 USC §3304(a)(2) as implemented by RFO 6.103-2; ( ) (3) Industrial Mobilization, Engineering, Developmental or Research Capability or Expert Services per 41 USC §3304(a)(3) as implemented by RFO 6.103-3; ( ) (4) International Agreement per 41 USC §3304(a)(4) as implemented by RFO 6.103-4 ( ) (5) Authorized or Required by Statute per 41 USC §3304(a)(5) as implemented by RFO 6.103-5; ( ) (6) National Security per 41 USC §3304(a)(6) as implemented by RFO 6.103-6; ( ) (7) Public Interest per 41 USC §3304(a)(7) as implemented by RFO 6.103-7; Demonstration that the Contractor s Unique Qualifications or Nature of the Acquisition Requires the Use of the Authority Cited Above (applicability of authority): Optum Infusion Services 308 LLC (Optum), is the only one source that is reasonably available because of urgency and who has agreed to continue to provide this highly specialized (hazardous drug compounding) supplies/services for our Oncology patients to ensure there are no unacceptable delays in patient care.

Optum maintains sterile compounding operations compliant with applicable regulatory standards, including USP 797 and USP 800, and is capable of providing patient-specific hazardous chemotherapy compounding consistent with the Statement of Work applicable to Louis A Johnson VA Medical Center. Hazardous oncology treatments are clinically time-sensitive, and a transition to an alternate provider would require onboarding and validation activities that may pose a risk of service interruption.

Description of Efforts Made to ensure that offers are solicited from as many potential sources as possible (including whether a notice was or will be publicized as required by RFO Part 5 and, if not, which exception under RFO Part 5 applies): In accordance with FAR 5.202(a)(2) The proposed contract action is made under the conditions described in 6.302-2 (or, for purchases conducted using simplified acquisition procedures, if unusual and compelling urgency precludes competition to the maximum extent practicable) and the Government would be seriously injured if the agency complies with the time periods specified in 5.203.

The continuing loss of in-house compounding capability creates an immediate requirement for an external provider to prepare and deliver prescribed hazardous medications within clinically required treatment timelines. Failure to establish this support as soon as possible would place oncology treatments at risk of interruption or delay. Due to flood remediation and the resulting loss of in-house hazardous-drug compounding capability, the facility requires immediate external compounding and delivery support to prevent interruption of scheduled Oncology treatments.

Delays associated with conducting a full and open competitive acquisition would risk interruption of patient care and adversely affect the Medical Center's ability to provide medically necessary chemotherapy treatments. The Government determined that continuation of services through Optum represents the most immediate and least disruptive means of maintaining continuity of care while acquisition actions for the follow-on requirement are completed.

This limited-source approach is based on the unusual and compelling urgency of the requirement rather than a determination that no other provider is capa

The description continues in the official notice.

Contracting contact

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 621610, a business counts as small if it has no more than $19.0 million in average annual receipts (SBA size standard). This notice is not set aside, but the size decides your small business status on it. SBA table, current as of Oct 15, 2026.

Companies that win this kind of work

Federal contractors paid for home health care services work, who also hold VA contracts (last 12 months): possible competitors, or partners to team with.

About the buyer

The Department of Veterans Affairs awarded $83.5 billion in contracts in the last 12 months; its biggest suppliers were Optum Public Sector Solutions, Inc., Mckesson Corporation and Triwest Healthcare Alliance Corp. See what VA is buying now.

Similar open home health care services bids

Great Lakes Region Durable Medical Equipment (DME) Delivery Services
Department of Veterans Affairs
Due Nov 20, 2026, 6:00 AM (UTC-6) · 2 days left
Presolicitation · Posted Nov 6, 2026